ArticleFrontiers in neurology2023

Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan.

Shiho Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.